Across TCGA cell cohorts, SFT2D1 RNA expression is significantly associated with the go_rna of many other GO terms, with 2,097 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible SFT2D1-associated GO terms across cancer lineages are 7-methylguanosine RNA capping, 7-methylguanosine mRNA capping, and Negative regulation of ubiquitin protein ligase activity. Each is linked with SFT2D1 in more than 8 cancer types. Because this analysis shows association rather than direction, both SFT2D1-to-partner and partner-to-SFT2D1 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (SFT2D1→partner) and Y-score (partner→SFT2D1) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
OVARY	7-methylguanosine RNA capping →	+0.098	+0.489	.002	.004	3	9
OVARY	7-methylguanosine mRNA capping →	+0.098	+0.489	.002	.004	3	9
KIDNEY	Negative regulation of ubiquitin protein ligase activity →	+0.165	+0.594	<.001	<.001	3	8
STOMACH	Pyruvate transmembrane transport →	+0.255	+1.042	.001	<.001	3	7
LIVER	Negative regulation of amyloid-beta clearance →	+0.136	+1.056	.001	<.001	2	8
STOMACH	Pyruvate transport →	+0.259	+1.010	.001	.002	3	7

Each partner links to its Q-omics profile. Showing the 6 strongest of 2,097 associations by consensus.

Exploration

SFT2D1 survival (RNA) · tumor vs normal (RNA) · all SFT2D1 data types